189 related articles for article (PubMed ID: 30342171)
1. Summary report of second EUFEPS/AAPS conference on global harmonization in bioequivalence.
Chen ML; Blume H; Beuerle G; Mehta M; Potthast H; Brandt A; Schug BS; Ducharme M; Endrenyi L; Gallicano K; Schuirmann D; Welink J
Eur J Pharm Sci; 2019 Jan; 127():24-28. PubMed ID: 30342171
[TBL] [Abstract][Full Text] [Related]
2. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
[TBL] [Abstract][Full Text] [Related]
3. The global bioequivalence harmonisation initiative: Report of EUFEPS/AAPS third conference.
Mehta M; Blume H; Beuerle G; Tampal N; Schug B; Potthast H; Jiang W; Wilson C
Eur J Pharm Sci; 2020 Aug; 151():105383. PubMed ID: 32473200
[TBL] [Abstract][Full Text] [Related]
4. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference.
Hh B; M M; G B; A D; G H; W J; A K; J L; H P; B S; A S; N T; Tsang YC; J W; J W
Eur J Pharm Sci; 2021 Dec; 167():105987. PubMed ID: 34481066
[TBL] [Abstract][Full Text] [Related]
5. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference.
Mehta M; Schug B; Blume HH; Beuerle G; Jiang W; Koenig J; Paixao P; Tampal N; Tsang YC; Walstab J; Wedemeyer R; Welink J
Eur J Pharm Sci; 2023 Nov; 190():106566. PubMed ID: 37591469
[TBL] [Abstract][Full Text] [Related]
6. Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report.
Chen ML; Shah VP; Crommelin DJ; Shargel L; Bashaw D; Bhatti M; Blume H; Dressman J; Ducharme M; Fackler P; Hyslop T; Lutter L; Morais J; Ormsby E; Thomas S; Tsang YC; Velagapudi R; Yu LX
Eur J Pharm Sci; 2011 Nov; 44(4):506-13. PubMed ID: 21946259
[TBL] [Abstract][Full Text] [Related]
7. Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report.
Chen ML; Shah VP; Crommelin DJ; Shargel L; Bashaw D; Bhatti M; Blume H; Dressman J; Ducharme M; Fackler P; Hyslop T; Lutter L; Morais J; Ormsby E; Thomas S; Tsang YC; Velagapudi R; Yu LX
AAPS J; 2011 Dec; 13(4):556-64. PubMed ID: 21845486
[TBL] [Abstract][Full Text] [Related]
8. Bio-International 92, conference on bioavailability, bioequivalence, and pharmacokinetic studies.
Blume HH; Midha KK
J Pharm Sci; 1993 Nov; 82(11):1186-9. PubMed ID: 7904641
[TBL] [Abstract][Full Text] [Related]
9. Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences.
Mochel JP; Tyden E; Hellmann K; Vendrig JC; Şenel S; Dencker L; Cristina RT; Linden H; Schmerold I
J Vet Pharmacol Ther; 2018 Jun; 41(3):378-383. PubMed ID: 29266320
[TBL] [Abstract][Full Text] [Related]
10. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.
Shah VP; Midha KK; Dighe S; McGilveray IJ; Skelly JP; Yacobi A; Layloff T; Viswanathan CT; Cook CE; McDowall RD
Eur J Drug Metab Pharmacokinet; 1991; 16(4):249-55. PubMed ID: 1823867
[TBL] [Abstract][Full Text] [Related]
11. Open forum conference on the ICH M13A bioequivalence guideline.
Blume H; Wedemeyer S; Seidlitz A; Beuerle G; Klein S; Bilensoy E
Eur J Pharm Sci; 2024 May; 196():106741. PubMed ID: 38452875
[TBL] [Abstract][Full Text] [Related]
12. Conference report: Bio-International 2005.
Midha KK; Shah VP; Singh GJ; Patnaik R
J Pharm Sci; 2007 Apr; 96(4):747-54. PubMed ID: 17094144
[TBL] [Abstract][Full Text] [Related]
13. Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays.
Miranda-Pérez de Alejo C; Aceituno Álvarez A; Mendes Lima Santos G; Fernández Cervera M; Jung-Cook H; Cabrera-Pérez MÁ
Ther Innov Regul Sci; 2021 Jan; 55(1):65-81. PubMed ID: 32602028
[TBL] [Abstract][Full Text] [Related]
14. AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns.
Martinez MN; McGilveray I
AAPS PharmSci; 2003 Oct; 5(4):E27. PubMed ID: 15198515
[TBL] [Abstract][Full Text] [Related]
15. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.
Löbenberg R; Amidon GL
Eur J Pharm Biopharm; 2000 Jul; 50(1):3-12. PubMed ID: 10840189
[TBL] [Abstract][Full Text] [Related]
16. Conference report: Bioanalysis highlights from the 2012 American Association of Pharmaceutical Scientists National Biotechnology Conference.
Crisino RM; Geist B; Li J
Bioanalysis; 2012 Sep; 4(17):2103-7. PubMed ID: 23013391
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability and bioequivalence: focus on physiological factors and variability.
Karalis V; Macheras P; Van Peer A; Shah VP
Pharm Res; 2008 Aug; 25(8):1956-62. PubMed ID: 18551249
[TBL] [Abstract][Full Text] [Related]
18. AAPS Workshop Report on ICH M10.
Booth B; Vazvaei F; Fluhler E; Myler H; Woolf E
AAPS J; 2019 Dec; 22(1):10. PubMed ID: 31823177
[TBL] [Abstract][Full Text] [Related]
19. A time to speak out on bioequivalence and therapeutic equivalence.
Dettelbach HR
J Clin Pharmacol; 1986; 26(5):307-8. PubMed ID: 2871052
[No Abstract] [Full Text] [Related]
20. Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary report.
Chen ML; Shah VP; Ganes D; Midha KK; Caro J; Nambiar P; Rocci ML; Thombre AG; Abrahamsson B; Conner D; Davit B; Fackler P; Farrell C; Gupta S; Katz R; Mehta M; Preskorn SH; Sanderink G; Stavchansky S; Temple R; Wang Y; Winkle H; Yu L
AAPS J; 2010 Sep; 12(3):371-7. PubMed ID: 20440588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
